UNSPSC 51341807: Daclatasvir

Antiviral for the treatment of Hepatitis C virus infections

UNSPSC 51341807 Daclatasvir, a Commodity code, represents pharmaceutical procurement by state and local health agencies. However, recent state and local solicitations tagged under this code do not align with daclatasvir (a hepatitis C antiviral) — instead, they document purchases of unrelated pharmaceuticals including antibiotics, naloxone, and drug deactivation systems through piggyback contracts and competitive bids. The code shows minimal relevant recent activity; the two posted opportunities target different drug classes and delivery models than the code's nominal scope suggests.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over 12 months plus two renewal options, for supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium (completed award, not an open solicitation). Seminole County, Florida issued an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. Activity appears scattered across state health departments and county health systems in Illinois and Florida, with no clear pattern supporting sustained pursuit of daclatasvir-specific opportunities under this code designation.